A one-filter-three-probe assay for defective interference (DI) effects of naturally occurring core internal deletion (CID) variants of human hepatitis B virus
1 Department of Pathology, WHO Collaborating Center for Tropical Diseases, Sealy Center for Vaccine Developments, University of Texas Medical Branch, Galveston, USA.